These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 21813680)
41. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Lehmann M; Ghosh PM; Madison C; Laforce R; Corbetta-Rastelli C; Weiner MW; Greicius MD; Seeley WW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD Brain; 2013 Mar; 136(Pt 3):844-58. PubMed ID: 23358601 [TBL] [Abstract][Full Text] [Related]
42. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease. Fan Z; Okello AA; Brooks DJ; Edison P Brain; 2015 Dec; 138(Pt 12):3685-98. PubMed ID: 26510952 [TBL] [Abstract][Full Text] [Related]
43. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Li Y; Rinne JO; Mosconi L; Pirraglia E; Rusinek H; DeSanti S; Kemppainen N; Någren K; Kim BC; Tsui W; de Leon MJ Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2169-81. PubMed ID: 18566819 [TBL] [Abstract][Full Text] [Related]
44. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Desgranges B; Baron JC; de la Sayette V; Petit-Taboué MC; Benali K; Landeau B; Lechevalier B; Eustache F Brain; 1998 Apr; 121 ( Pt 4)():611-31. PubMed ID: 9577389 [TBL] [Abstract][Full Text] [Related]
45. Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden. Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA Neurology; 2017 May; 88(18):1759-1767. PubMed ID: 28381517 [TBL] [Abstract][Full Text] [Related]
46. Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not. Sang S; Pan X; Chen Z; Zeng F; Pan S; Liu H; Jin L; Fei G; Wang C; Ren S; Jiao F; Bao W; Zhou W; Guan Y; Zhang Y; Shi H; Wang Y; Yu X; Wang Y; Zhong C Alzheimers Res Ther; 2018 Mar; 10(1):26. PubMed ID: 29490669 [TBL] [Abstract][Full Text] [Related]
47. Brain glucose metabolism and its relation to amyloid load in middle-aged adults with childhood-onset epilepsy. Joutsa J; Rinne JO; Karrasch M; Hermann B; Johansson J; Anttinen A; Eskola O; Helin S; Shinnar S; Sillanpää M; Epilepsy Res; 2017 Nov; 137():69-72. PubMed ID: 28950220 [TBL] [Abstract][Full Text] [Related]
48. Spatial Patterns of Hypometabolism and Amyloid Deposition in Variants of Alzheimer's Disease Corresponding to Brain Networks: a Prospective Cohort Study. Wang Y; Shi Z; Zhang N; Cai L; Li Y; Yang H; Yao S; Xing X; Ji Y; Gao S Mol Imaging Biol; 2019 Feb; 21(1):140-148. PubMed ID: 29869063 [TBL] [Abstract][Full Text] [Related]
49. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. Cohen AD; Price JC; Weissfeld LA; James J; Rosario BL; Bi W; Nebes RD; Saxton JA; Snitz BE; Aizenstein HA; Wolk DA; Dekosky ST; Mathis CA; Klunk WE J Neurosci; 2009 Nov; 29(47):14770-8. PubMed ID: 19940172 [TBL] [Abstract][Full Text] [Related]
50. Frontotemporal network connectivity during memory encoding is increased with aging and disrupted by beta-amyloid. Oh H; Jagust WJ J Neurosci; 2013 Nov; 33(47):18425-37. PubMed ID: 24259567 [TBL] [Abstract][Full Text] [Related]
51. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly. Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404 [TBL] [Abstract][Full Text] [Related]
52. Associations of thyroid hormone serum levels with in-vivo Alzheimer's disease pathologies. Choi HJ; Byun MS; Yi D; Sohn BK; Lee JH; Lee JY; Kim YK; Lee DY; Alzheimers Res Ther; 2017 Aug; 9(1):64. PubMed ID: 28818092 [TBL] [Abstract][Full Text] [Related]
53. Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease. Pardo JV; Lee JT; eNeuro; 2018; 5(1):. PubMed ID: 29497704 [TBL] [Abstract][Full Text] [Related]
54. High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters. Forsberg A; Almkvist O; Engler H; Wall A; Långström B; Nordberg A Curr Alzheimer Res; 2010 Feb; 7(1):56-66. PubMed ID: 20205671 [TBL] [Abstract][Full Text] [Related]
55. Metabolic Syndrome and Amyloid Accumulation in the Aging Brain. Gomez G; Beason-Held LL; Bilgel M; An Y; Wong DF; Studenski S; Ferrucci L; Resnick SM J Alzheimers Dis; 2018; 65(2):629-639. PubMed ID: 30103324 [TBL] [Abstract][Full Text] [Related]
56. Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline. Hanseeuw BJ; Betensky RA; Schultz AP; Papp KV; Mormino EC; Sepulcre J; Bark JS; Cosio DM; LaPoint M; Chhatwal JP; Rentz DM; Sperling RA; Johnson KA Ann Neurol; 2017 Apr; 81(4):583-596. PubMed ID: 28253546 [TBL] [Abstract][Full Text] [Related]
57. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B. Meyer PT; Hellwig S; Amtage F; Rottenburger C; Sahm U; Reuland P; Weber WA; Hüll M J Nucl Med; 2011 Mar; 52(3):393-400. PubMed ID: 21321269 [TBL] [Abstract][Full Text] [Related]